疼痛管理設備市場：按類型、應用程式、最終用戶和地區分類

預計到2026年，疼痛管理設備市場規模將達到51.81億美元，2033年將達到81.577億美元。預計從2026年到2033年，該市場將以6.7%的複合年成長率成長。

疼痛管理設備包括用於治療癌症疼痛、傷害性疼痛和肌肉骨骼疼痛的設備。市面上提供多種疼痛治療設備，包括消融設備、經皮神經刺激設備（TENS）、鎮痛輸注幫浦和脊髓刺激設備。這些設備透過多種方式緩解疼痛，例如直接靶向疼痛源、阻斷疼痛訊號或直接向患處給藥。諮詢醫療專業人員以確定最適合個人需求和病情的疼痛管理設備至關重要。只有在創傷較小、費用較低的治療方法無法緩解疼痛和痛苦時，才應考慮使用昂貴且有創的植入式裝置作為有效的治療方法。如果使用得當且適用於適當的患者，脊髓刺激可以對神經性疼痛訊號產生神經調節作用，但對傷害性疼痛訊號卻沒有作用。因此，在療效得到檢驗的患者中，長期疼痛緩解率約為 60-80%。

市場動態

神經調控設備主要用於治療和緩解神經系統疾病的症狀，例如疼痛、癲癇、震顫和中風。此外，它們也用於治療各種與老齡化相關的疾病和神經症。神經系統疾病盛行率的不斷上升、非鴉片類藥物療法的日益普及以及神經刺激設備帶來的許多益處，都在推動市場擴張。

本次調查的主要特點

• 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、技術進步、區域展望以及主要參與者採取的競爭策略的重要見解。
• 本研究根據以下參數創建了全球疼痛管理設備市場主要公司的概況：公司亮點、產品系列、關鍵亮點、財務表現和策略。
• 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
• 全球疼痛管理設備市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 透過分析全球疼痛管理設備市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因子
  • 市場機遇
• 影響分析
• 近期產品發布
• 技術進步
• 併購和合作
• 監管趨勢
• 主要進展
• PEST分析

第4章 全球疼痛管理設備市場：按類型分類，2021-2033年

• 神經調控與神經刺激裝置
• 止痛藥輸注泵
• 消融裝置

第5章 全球疼痛管理設備市場：依應用領域分類，2021-2033年

• 神經病變疼痛
• 癌症疼痛
• 臉部疼痛和偏頭痛
• 肌肉骨骼疼痛
• 其他

第6章 全球疼痛管理設備市場：依最終用戶分類，2021-2033年

• 醫院
• 診所
• 其他

第7章 全球疼痛管理設備市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲國家
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太國家
• 中東
  • GCC
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第8章 競爭情勢

• Stryker Corporation
• Pfizer Inc.（Hospira Inc.）
• Medtronic Plc
• Boston Scientific Corporation
• Baxter International Inc.
• B.Braun Melsungen AG
• Abbott Laboratories
• Colfax Corporation（Djo Global LLC）
• Kimberly-Clark Corporation（Baylis Medical）
• Johnson & Johnson（Codman and Shurtleff, Inc.）
• Neuspera Medical
• ZetrOZ Systems
• Therabody
• BioElectronics Corporation
• Nevro Corp.
• Stevanato Group SpA
• Bexson Biomedical, Inc.
• SPR Therapeutics
• Lumaflex
• Saluda Medical Pty Limited
• DyAnsys Inc.
• Pacira BioSciences, Inc.
• InterSystems
• Nalu Medical, Inc.
• StimaWELL North America Inc.

第9章

• 調查方法
• 關於本公司

Pain Management Devices Market is estimated to be valued at USD 5,181.0 Mn in 2026 and is expected to reach USD 8,157.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.7% from 2026 to 2033.

Pain management devices include those for cancer pain, nociceptive pain, musculoskeletal pain, and others. There are many different kinds of pain treatment equipment on the market, including ablation devices, transcutaneous electrical nerve stimulators, analgesic infusion pumps, and spinal cord stimulators. These devices work by targeting the source of pain and providing relief through various methods, such as blocking pain signals or releasing medication directly to the affected area. It is important to consult with a healthcare professional to determine the best pain management device for individual needs and conditions. Costly and invasive implantable devices should only be utilized as effective treatments when less aggressive and expensive ones have failed to relieve pain and suffering. When used for the correct reasons by the right people, spinal cord stimulation neuromodulates neuropathic pain signals but not nociceptive pain signals. This results in roughly 60-80% long-term pain alleviation in patients who were tested for efficacy.

Market Dynamics

Devices for neuromodulation are primarily used to treat and reduce the symptoms of neurological illnesses', such as pain, epilepsy, tremor, stroke, etc. Additionally, neuromodulation devices are usedto treat a variety of illnesses linked to aging and neurotic conditions. The prevalence of neurological illnesses is increasing, non-opioid treatments are becoming more popular, and neurostimulation devices provide a variety of advantages, all of which contribute to the market's expansion.

Key features of the study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, technology advancement, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global pain management devices market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Stryker Corporation, Pfizer Inc. (Hospira Inc.), Medtronic Plc, Boston Scientific Corporation, Baxter International Inc., Braun Melsungen AG, Abbott Laboratories, Colfax Corporation (Djo Global LLC), Kimberly-Clark Corporation (Baylis Medical), Johnson & Johnson (Codman and Shurtleff, Inc.), Neuspera Medical, ZetrOZ Systems, Therabody, BioElectronics Corporation, Nevro Corp, Stevanato Group S.p.A., Bexson Biomedical, Inc., SPR Therapeutics, Lumaflex, Saluda Medical Pty Limited, DyAnsys Inc., Pacira BioSciences, Inc., InterSystems, Nalu Medical, Inc., and StimaWELL North America Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global pain management devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pain management devices market.

Market Segmentation

• Global Pain Management Devices Market, By Type (Revenue, USD Mn, 2021 - 2033)
• Neuromodulation & Neurostimulation Devices
• Analgesic Infusion Pumps
• Ablation Devices
• Global Pain Management Devices Market, By Application (Revenue, USD Mn, 2021 - 2033)
• Neuropathic Pain
• Cancer Pain
• Facial & Migraine Pain
• Musculoskeletal Pain
• Others
• Global Pain Management Devices Market, By End User (Revenue, USD Mn, 2021 - 2033)
• Hospitals
• Clinics
• Others
• Global Pain Management Devices Market, By Region (Revenue, USD Mn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
• Stryker Corporation
• Pfizer Inc. (Hospira Inc.)
• Medtronic Plc
• Boston Scientific Corporation
• Baxter International Inc.
• Braun Melsungen AG
• Abbott Laboratories
• Colfax Corporation (Djo Global LLC)
• Kimberly-Clark Corporation (Baylis Medical)
• Johnson & Johnson (Codman and Shurtleff, Inc.)
• Neuspera Medical
• ZetrOZ Systems
• Therabody Inc.
• BioElectronics Corporation
• Nevro Corp.
• Stevanato Group S.p.A.
• Bexson Biomedical, Inc.
• SPR Therapeutics
• Lumaflex
• Saluda Medical Pty Limited
• DyAnsys Inc.
• Pacira BioSciences, Inc.
• InterSystems
• Nalu Medical, Inc.
• StimaWELL North America Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Product Launches
• Technology Advancement
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Pain Management Devices Market, By Type, 2021-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Neuromodulation & Neurostimulation Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Analgesic Infusion Pumps
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Ablation Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Pain Management Devices Market, By Application, 2021-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Neuropathic Pain
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Cancer Pain
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Facial & Migraine Pain
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Musculoskeletal Pain
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Pain Management Devices Market, By End User, 2021-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Pain Management Devices Market, By Region, 2021-2033, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2021 - 2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Stryker Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Pfizer Inc. (Hospira Inc.)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Medtronic Plc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Baxter International Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• B.Braun Melsungen AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Colfax Corporation (Djo Global LLC)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Kimberly-Clark Corporation (Baylis Medical)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Johnson & Johnson (Codman and Shurtleff, Inc.)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Neuspera Medical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ZetrOZ Systems
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Therabody
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• BioElectronics Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Nevro Corp.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Stevanato Group S.p.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bexson Biomedical, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• SPR Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Lumaflex
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Saluda Medical Pty Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• DyAnsys Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Pacira BioSciences, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• InterSystems
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Nalu Medical, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• StimaWELL North America Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

9. Section

• Research Methodology
• About Us